Investigation of the effects of intake of the food containing the lactic acid bacteria on gut environment - Investigation of the effects of intake of the food containing the lactic acid bacteria on gut environment

Metagen, Inc.0 sites40 target enrollmentFebruary 9, 2023

ConditionsHealthy male/female adults

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy male/female adults
Sponsor: Metagen, Inc.
Enrollment: 40
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

February 9, 2023

End Date

March 10, 2023

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Metagen, Inc.

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\)Subjects who have a plan or who have taken the food containing lactic acid bacteria within a month before the trial start, which would affect the trial result. (2\)Subjects who are regularly consuming foods for specified health uses, foods with function claims, supplement and/or health foods, which would affect the trial results for more than 3 times a week. (3\)Subjects who have a plan or who have taken medication within a month before the pre\-test start, which would affect the trial result. (4\)Subjects who had undergone appendectomy. (5\)Subjects who have received the surgery which would affect the trial result within half a year before obtaining a consent. (6\)Subjects who are expected to undergo major changes in their living environment such as home and work during this trial. (7\)Subjects with irregular dietary habits. (8\)Subjects whose roomer is planning to join this trial. (9\)Subjects who take excessive alcohol. (10\)Subjects who have previous/current medical history of severe cardiac, hepatic, renal or digestive diseases. (11\)Pregnant, possibly pregnant, or lactating women. (12\)Subjects who are allergic to medicines and test foods (related to lactic acid bacteria). (13\)Subjects who are now under other clinical tests with some kind of medicine/food, or participated in those within a month before this trial, or will join those after giving informed consent to participate in this trial. (14\-16\)Subjects who donated their blood components, and/or whole blood as below \- all subjects: 200 mL within a month \- males: 400 mL within the last 3 months \- females: 400 mL within the last 4 months to this trial. (17\-18\)Subjects whose collected blood volume within the last 12 months would reach to the following criteria after adding the blood collection in this study; \- males: 1,200 mL \- females: 800 mL (19\) Others who have been determined ineligible by the principal/sub investigator.